Research_
ToGeTher: Type One diabetes Gut Therapy Trial
The University of Sydney is looking for adults living with type 1 diabetes to trial a new specialised fibre supplement.
Previous studies have shown the gut bacteria is different in people with type 1 diabetes compared to those without. The fibre supplement has been shown to have beneficial effects on the gut bacteria, which may have impacts on blood glucose levels and overall health.
Participation in this study will involve attending the University of Sydney, Charles Perkins Centre, on five separate occasions over 12 weeks (1 x initial 30 min screening visit and, if eligible, 3 x 3 hour and 1 x 1 hour sessions).
During these sessions you will have a blood test, provide a urine sample, have a CGM inserted, and your blood pressure, height and weight will be measured.
You will be provided with a fibre supplement and a plan on how much and when to consume throughout the weeks. You will be asked to provide stool and urine samples and to complete food diaries and questionnaires.
In exchange of your time, you will be reimbursed with a Coles/Myer gift card at each visit (excluding screening).
Ethics approval number: X18-0166
Eligibility
You may be eligible to participate in this study if you:
- are aged 18-45 years
- have been diagnosed with type 1 diabetes for at least six months
- have an HbA1c less than or equal to 8.5%
- do not have coeliac disease or any other gastrointestinal disease
- are not pregnant or breastfeeding
How to participate
If you are interested in assisting with this important and exciting area of research, please contact the trial coordinator, Dr Kirstine Bell.
